Lufthansa Group has begun integrating ITA Airways after acquiring a 41% stake, starting with loyalty programmes and moving to ...

In Palm Springs, the challenges of the terrain and atmosphere reshaped the work of these architects over time – these circumstances created a specific school of architectural ideas that inspired them ...

Julius Baer will present a strategy update, including new medium-term targets, ahead of summer 2025. More details, including exact timing and venue, are expected to be communicated together with the ...

A daily intake of one gram of omega-3s can slow down biological aging by up to four months, according to an analysis of clinical data from the international DO-HEALTH study led by the University of ...

Taking a daily omega-3 supplement appears to slow down the rate of biological ageing by up to four months, according to a study by researchers at th ...

UBS published its first Global Entrepreneur Report, based on a survey of 156 UBS entrepreneur clients and network members across a full range of businesses accounting for approximately USD 19.1 ...

We must reassess our levels of engagement in a world dominated by sound bites and social media. There is transformative power in genuine dialogue I was among the 50 attendees from Asia and Europe at ...

Howden has disclosed that adjusted revenue grew by 23% to £3.01 billion in 2024, with organic growth of 30% in its ...

Leonteq AG (SIX: LEON) publishes today its full-year 2024 results and informs about its new enhanced regulatory regime. In a separate press release, Leonteq also announces the appointment of Christian ...

We've got you covered with a comprehensive breakdown of the must-see spots in Switzerland, for skiing enthusiasts and nature ...

CFC, a specialist insurance provider focused on emerging risks and cyber, has promoted James Burns to Global Head of Cyber ...

ACLF clinical trials expected to initiate in 1Q253 clinical data readouts expected by year-end 2025 across the ACLF pipeline, including on-going UNVEIL-IT® Phase 2 trialData of on-going Phase 1b also ...